Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06867861 · ClinicalTrials.gov registry record · NA
Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
A NA study of Gestational Diabetes Mellitus (GDM), sponsored by Eastern Virginia Medical School.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT06867861 is a NA study of Gestational Diabetes Mellitus (GDM) that is actively recruiting participants, run by Eastern Virginia Medical School. The registered enrollment target is 110 participants, below the 816-participant average among 4 other Gestational Diabetes Mellitus (GDM) trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06867861, a NA study of Gestational Diabetes Mellitus (GDM), is actively recruiting participants, sponsored by Eastern Virginia Medical School.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Fiber
Study Locations (1)
Virginia
- Macon & Joan Brock Virginia Health Sciences at ODU - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2025-02-24 |
| Est. Completion | 2026-08-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06867861
The ClinicalTrials.gov registry entry for NCT06867861 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 4 other Gestational Diabetes Mellitus (GDM) trials with a reported enrollment target (87% lower). The listed sponsor is Eastern Virginia Medical School, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gestational Diabetes Mellitus (GDM) appearing as the primary indexed condition, and to 1 intervention - of which Fiber is the first listed.
NCT06867861 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06867861 about?
NCT06867861 is a clinical study titled "Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes". The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized contro...
What is the current status of trial NCT06867861?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2025-02-24. Estimated completion is 2026-08-26.
What conditions does trial NCT06867861 study?
This clinical trial studies the following conditions: Gestational Diabetes Mellitus (GDM).
What interventions are being tested in trial NCT06867861?
The interventions under investigation include: Fiber (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06867861?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06867861 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes Mellitus (GDM)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Validating CGM for GDM
RECRUITING · NA
-
Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
RECRUITING · NA
-
The Impact of Gestational Diabetes Mellitus on Cerebral Blood Flow and Cerebrovascular Function After Pregnancy
RECRUITING · Phase 1
-
Maternal Obesity, Breast Milk Composition, and Infant Growth
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.